NUVAXOVID Trademark

Trademark Overview

On Saturday, July 25, 2020, a trademark application was filed for NUVAXOVID with the United States Patent and Trademark Office. The USPTO has given the NUVAXOVID trademark a serial number of 90073526. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2024. This trademark is owned by Novavax, Inc.. The NUVAXOVID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines; consulting services in the field of research and development of Covid-19 vaccines; Covid-19 vaccine research and development
nuvaxovid

General Information

Serial Number90073526
Word MarkNUVAXOVID
Filing DateSaturday, July 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines; consulting services in the field of research and development of Covid-19 vaccines; Covid-19 vaccine research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 25, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Wednesday, July 29, 2020NEW APPLICATION ENTERED
Tuesday, August 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 11, 2020ASSIGNED TO EXAMINER
Wednesday, November 11, 2020SUSPENSION LETTER WRITTEN
Wednesday, November 11, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, November 11, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 10, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 11, 2021SUSPENSION LETTER WRITTEN
Thursday, February 11, 2021LETTER OF SUSPENSION E-MAILED
Thursday, February 11, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 6, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, April 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 6, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 5, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 5, 2021SOU EXTENSION 1 FILED
Friday, November 5, 2021SOU EXTENSION 1 GRANTED
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 22, 2022SOU EXTENSION 2 FILED
Tuesday, February 22, 2022SOU EXTENSION 2 GRANTED
Thursday, February 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 25, 2022SOU EXTENSION 3 FILED
Monday, July 25, 2022SOU EXTENSION 3 GRANTED
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 4 FILED
Thursday, April 13, 2023SOU EXTENSION 4 GRANTED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 27, 2023SOU EXTENSION 5 FILED
Thursday, December 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 7, 2023SOU EXTENSION 5 GRANTED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 12, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

nuvaxovid covid vaccines research trials field development related vaccine consulting market